Explore 3 Stock Ideas & Industry Insights Download Free Report

Integrated Cannabis Solutions Inc

Company price
0.0004 USD 0.00(0%)
Last update at 2026-11-16T21:00:00Z
VOLUME
3335500
Market Cap
14.02M

Momentum Score

…

Integrated Cannabis Solutions, Inc. focuses on the growing and processing of hemp or biomass in the United States. The company intends to sell processed material in the form of Cannabidiol (CBD) or isolate to manufacturers or pharmaceutical companies for their manufacture, distribution, and sale of CBD related products, such as edibles for human consumption, vitamins, multi-vitamins, and topical products for human use comprises oils, tinctures, creams, oils and salves, and vaping liquids. Further, it is planning to promote and assist in the establishment of a co-op with local farmers for establishing a consistent supply of biomass and enter into long term purchase contracts. The company was formerly known as Integrated Parking Solutions, Inc. and changed its name to Integrated Cannabis Solutions, Inc. in April 2014. Integrated Cannabis Solutions, Inc. was founded in 2003 and is headquartered in Coconut Creek, Florida.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.00
Low
0.00
High
52 Week Price Range
0.00
Low
0.00
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Public information on Integrated Cannabis Solutions Inc (IGPK) is limited; the company is an OTC Pink‑listed microcap linked to the cannabis industry. Long-term growth drivers for such firms include broader legalization, rising consumer demand, and successful scaling of product or service offerings, which IGPK may benefit from if it secures capital and executes its plans.

Key investment risks include limited disclosure and liquidity as an OTC Pink microcap, weak operating track record, potential dilution, and regulatory uncertainty that could hinder execution.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.00
Dividend Yield
-
Revenue TTM
2.02M
Revenue Per Share
0.20
Gross Profit TTM
-0.18M
Debt / Equity
-0.95
ROE
-
Net Debt
-4.51M
ROCE
5.80%
Diluted EPS TTM
-

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 0.68M 0.92M 0.63M -0.46M -0.37M
Net income 0.68M 0.92M 0.63M -0.46M -0.42M
Selling general administrative - - - - 0.33M
Gross profit 1.80M 2.10M 0.89M 0.10M -
Ebit - - 1.61M -0.34M -0.33M
Ebitda 0.34M 0.92M 1.62M -0.33M -0.33M
Depreciation and amortization - - 0.01M 0.01M -
Operating income 0.34M 0.92M 0.23M -0.34M -0.33M
Other operating expenses 73.70M 61.91M 0.97M 1.54M 0.33M
Interest expense - - - 0.12M 0.05M
Net interest income - - - - -0.05M
Income tax expense - - -0.17M -0.00M 0.05M
Total revenue 74.05M 62.83M 1.19M 1.20M 0.00M
Total operating expenses 1.46M 1.18M 0.67M 0.44M 0.33M
Cost of revenue 72.25M 60.73M 0.30M 1.10M -
Total other income expense net 0.34M 0.00M 0.41M -0.12M -0.05M
Net income from continuing ops - - - - -0.37M
Net income applicable to common shares - - - - -0.37M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 5.83M 5.56M - 0.80M 0.01M
Intangible assets - - - 0.22M -
Other current assets 0.05M 0.36M - 0.00M 0.01M
Total liab -0.11M 0.01M - 2.84M 1.07M
Total stockholder equity 5.94M 5.55M - -2.04M -1.06M
Other current liab 0.02M 0.01M - 0.72M 0.50M
Common stock 0.45M 0.45M - 0.20M 0.16M
Capital stock - - - - 0.16M
Retained earnings -0.77M -1.45M - -1.22M -3.83M
Other assets - 0.00M - - -
Cash 4.51M 3.95M - 0.03M -
Total current liabilities -0.11M 0.01M - 2.10M 1.07M
Net debt -4.51M -3.95M - 1.92M 0.55M
Short term debt - - - 1.20M 0.55M
Short long term debt - - - - 0.55M
Short long term debt total - - - 1.95M 0.55M
Other stockholder equity 6.25M 6.55M - -0.83M 2.61M
Total current assets 5.38M 5.14M - 0.36M 0.01M
Net tangible assets - - - - -1.06M
Net receivables 0.81M 0.82M - 0.06M -
Inventory - - - 0.27M -
Accounts payable -0.13M - - 0.17M 0.02M
Accumulated other comprehensive income - - - -0.19M -
Non currrent assets other - -0.00M - 0.01M -
Non current assets total 0.45M 0.42M - 0.44M 0.00M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Change to liabilities - - - - 0.17M
Total cashflows from investing activities -0.03M -0.42M - -0.01M -
Net borrowings - - - - 0.21M
Total cash from financing activities -0.29M 4.63M -1.61M 0.11M 0.21M
Change to operating activities - - - - -0.01M
Net income 0.68M 0.92M 0.63M -0.46M -0.37M
Change in cash 0.56M 3.95M -0.03M -0.03M 0.21M
Begin period cash flow 3.95M 0.00M 0.03M 0.06M 0.00M
End period cash flow 4.51M 3.95M -2.44M 0.03M 0.00M
Total cash from operating activities 0.88M -0.26M 1.61M -0.13M -0.21M
Depreciation - - - 0.01M -
Other cashflows from investing activities - - -0.00M - -
Change to inventory - - - -0.12M -
Change to account receivables 0.01M -0.82M - -0.02M -
Other cashflows from financing activities - 0.41M -4.39M 0.05M 0.21M
Capital expenditures 0.00M 0.00M 0.00M 0.01M 0.00M
Change in working capital 0.20M -1.18M 1.46M 0.23M 0.17M
Other non cash items - 0.00M -0.49M 0.09M -
Free cash flow 0.88M -0.26M 2.90M -0.14M -0.21M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to EBITDA (x)
IGPK
Integrated Cannabis Solutions Inc
-
-%
0.00 - - - - -8.91
MKKGY
Merck KGaA ADR
0.40
1.22%
33.13 21.25 14.93 3.10 2.14 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien
-
-%
169.65 24.86 15.11 3.13 1.98 18.89
TAK
Takeda Pharmaceutical Co Ltd ADR
-
-%
21.64 - 10.96 0.01 1.20 23.11
TKPHF
Takeda Pharmaceutical Co. Ltd.
-
-%
43.15 - 10.66 0.01 1.16 23.11

Profile*

Integrated Cannabis Solutions Inc

Integrated Cannabis Solutions, Inc. focuses on the growing and processing of hemp or biomass in the United States. The company intends to sell processed material in the form of Cannabidiol (CBD) or isolate to manufacturers or pharmaceutical companies for their manufacture, distribution, and sale of CBD related products, such as edibles for human consumption, vitamins, multi-vitamins, and topical products for human use comprises oils, tinctures, creams, oils and salves, and vaping liquids. Further, it is planning to promote and assist in the establishment of a co-op with local farmers for establishing a consistent supply of biomass and enter into long term purchase contracts. The company was formerly known as Integrated Parking Solutions, Inc. and changed its name to Integrated Cannabis Solutions, Inc. in April 2014. Integrated Cannabis Solutions, Inc. was founded in 2003 and is headquartered in Coconut Creek, Florida.

6810 North State Road 7, Coconut Creek, FL, United States, 33073

954 906 0098

1

Name Title Year Born
Mr. Matthew P. Dwyer Chairman, Pres, CEO, CFO & Chief Accounting Officer 1966
Mr. Eugene L. Caiazzo CEO, President, CFO & Chairman NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…